Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Autor: Agrawal, Vaibhav, Croslin, Cindy *, Beltran, Asuscena L. *, Zhang, Jianying *, Palmer, Joycelynne *, Huynh-Tran, Quy *, Hernandez, Rochelle *, Thomas, Sandra *, Robbins, Marjorie *, Aribi, Ahmed *, Ali, Haris, Stein, Anthony S. *, Budde, Elizabeth L. *, Al Malki, Monzr M. *, Marcucci, Guido
Zdroj: In Blood 15 November 2022 140 Supplement 1:6235-6236
Databáze: ScienceDirect